Search

Search Constraints

You searched for: Author/Creator Tarantelli, Chiara

Search Results

1. In vitro anti‐lymphoma activity of the first‐in‐class pan‐NOTCH transcription inhibitor CB‐103. (9th December 2022)

3. Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma. Issue 3 (27th July 2022)

4. Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma. (27th June 2017)

5. Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP‐319 in pre‐clinical models of aggressive lymphomas. (29th July 2019)

6. The novel atypical retinoid ST5589 down‐regulates Aurora Kinase A and has anti‐tumour activity in lymphoma pre‐clinical models. (3rd August 2015)

7. Understanding the mechanism of action of pyrrolo[3, 2-b]quinoxaline-derivatives as kinase inhibitors. Issue 6 (19th May 2020)